TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

BEONE MEDICINES USA

OncologyGastroenterologyDermatology
Pharma

BEONE MEDICINES USA is a pharmaceutical company focused on Oncology, Gastroenterology, Dermatology. Key products include BRUKINSA.

2019
Since
1
Drugs
-
Trials
4
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

BRUKINSA 2025-06-10
Type 3 - New Dosage Form
BRUKINSA 2025-06-10
Type 3 - New Dosage Form
BRUKINSA 2025-01-24
Labeling
BRUKINSA 2024-06-04
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 88%
0 drugs Phase 3: 7 Phase 2: 1 Phase 1: 16
Gastroenterology 10%
0 drugs Phase 3: 1 Phase 1: 1
Dermatology 2%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Dermatology, Gastroenterology
Baxter specialty
Oncology, Dermatology
CASPER PHARMA LLC big-pharma
Oncology, Gastroenterology, Dermatology
Eli Lilly big-pharma
Oncology, Dermatology
Bayer big-pharma
Oncology, Dermatology